首页> 外文期刊>Dental materials >Novel in vitro comparative model of osteogenic and inflammatory cell response to dental implants
【24h】

Novel in vitro comparative model of osteogenic and inflammatory cell response to dental implants

机译:对牙种植体成骨和炎症细胞反应的新型体外比较模型

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives. Roughened dental implants promote mesenchymal stem cell (MSCs) osteoblastic differentiation, and hydrophilic modifications induce anti-inflammatory macrophages activation. While the effect of different surface modifications on osseointegration of commercial dental implants have been compared in vivo and clinically, the initial cellular response to these modifications often overlooked. We aimed to characterize the macrophage inflammatory response and MSC osteogenesis across different commercially available implants in vitro.Methods. Six commercially available rough implants [OsseoSpeed (TM) (Astra-Tech (TM), Implant A); Osseotite (R) (Biomet 3i (TM), Implant B); TiUnite (TM) (Nobel-Biocare (R), Implant C); Ti-SLA (R), (Implant D), Roxolid (R) (RXD-SLA, Implant E), RXD-SLActive (R) (Implant F) (Straumann (R))] were examined. Macrophages and MSCs were seeded directly on implants and cultured in custom vials. mRNA and protein levels of pro- (IL1B, IL6, IL17A, CXCL10, TNFa) and anti- (IL4, IL10, TGFB1) inflammatory markers were measured after 24 and 48 h in macrophages. Osteoblastic differentiation of MSCs was assessed after seven days by alkaline phosphatase activity, osteocalcin, and angiogenic, osteogenic, and inflammatory markers by ELISA and qPCR (n = 6/variable, ANOVA, post hoc Tukey HSD with alpha = 0.05).Results. Hydrophilic implant F induced the highest level of osteogenic factor released from MSCs and anti-inflammatory factors from macrophages with the lowest level of pro-inflammatory factors. Alternatively, implants A and C supported lower levels of osteogenesis and increased secretion of pro-inflammatory factors.Significance. In this study, we successfully evaluated differences in cell response to commercially available clinical implants using an in vitro model. Data from this model suggest that not all surface modification procedures generate the same cell response. (C) 2018 The Academy of Dental Materials. Published by Elsevier Inc.
机译:目标。粗糙的牙科植入物可促进间充质干细胞(MSCs)成骨细胞分化,亲水性修饰可诱导抗炎性巨噬细胞活化。尽管已经在体内和临床上比较了不同表面修饰对商用牙科植入物骨整合的影响,但通常忽略了对这些修饰的初始细胞反应。我们旨在表征不同商业化植入物在体外的巨噬细胞炎症反应和MSC成骨作用。六种市售粗糙植入物[OsseoSpeed(TM)(Astra-Tech(TM),植入物A); Osseotite(R)(Biomet 3i(TM),植入物B); TiUnite(TM)(Nobel-Biocare(R),植入物C);检查了Ti-SLA(R),(植入物D),Roxolid(R)(RXD-SLA,植入物E),RXD-SLActive(R)(植入物F)(Straumann(R))]。将巨噬细胞和MSC直接接种在植入物上,并在定制的小瓶中培养。在巨噬细胞中分别在24和48小时后测量促炎性标志物(IL1B,IL6,IL17A,CXCL10,TNFa)和抗炎性标志物(IL4,IL10,TGFB1)的mRNA和蛋白质水平。 7天后,通过碱性磷酸酶活性,骨钙素以及血管生成,成骨和炎症标记通过ELISA和qPCR评估MSC的成骨细胞分化(n = 6 /变量,ANOVA,Tukey HSD后HSD,α= 0.05)。结果。亲水性植入物F诱导MSCs释放的成骨因子水平最高,而巨噬细胞的促炎因子水平最低,促炎因子水平最低。或者,植入物A和C支持较低水平的成骨作用并增加促炎因子的分泌。在这项研究中,我们成功地使用体外模型评估了对市售临床植入物的细胞反应差异。来自该模型的数据表明,并非所有的表面修饰程序都会产生相同的细胞反应。 (C)2018牙科材料学院。由Elsevier Inc.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号